Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.44 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19260219 | 0.84 | CA2 (0.46) | KMT2AKCNN4MEN1KDM4ESMN1; SMN2 | |
| SCHEMBL4377967 | 0.82 | CYP2C19 (0.46) | KMT2AKIF11CYP2C19HIF1AHDAC3 | |
| SCHEMBL1829558 | 0.79 | MAPT (0.48) | KMT2AKIF11CYP2C19HIF1ACHRM2 | |
| SCHEMBL7213724 | 0.79 | KMT2A (0.50) | KMT2AKCNN4KIF11CYP2C19HIF1A | |
| SCHEMBL25432602 | 0.77 | KMT2A (0.48) | KMT2AKCNN4KIF11CYP2C19HIF1A | |
| SCHEMBL4366561 | 0.77 | KMT2A (0.48) | KMT2AKCNN4KIF11CYP2C19HIF1A | |
| SCHEMBL27372942 | 0.76 | KMT2A (0.49) | KMT2AMMP8MEN1LMNAL3MBTL1 | |
| SCHEMBL7208176 | 0.76 | KMT2A (0.47) | KMT2AKCNN4KIF11CYP2C19HIF1A | |
| Ammonia Solution, Strong SCHEMBL5356621 | 0.76 | KMT2A (0.47) | KMT2AKCNN4KIF11CYP2C19HIF1A | |
| SCHEMBL1527236 | 0.76 | KMT2A (0.47) | KMT2AKCNN4KIF11CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024024120-A1 | FRAGRANCE COMPOSITION AND FOOD OR BEVERAGE | 高砂香料工業株式会社 | 2024-02-01 | — | — | WO | disclosed |
| CN-103561713-B | There is the compositions of the strong degree of effective spice | 宝洁公司 | 2016-11-02 | — | — | CN | disclosed |
| CN-101611129-B | Benefit agent delivery compositions | PROCTER & GAMBLE | 2014-06-18 | — | — | CN | disclosed |
| CN-103561713-A | Compositions comprising an efficient perfume bloom | PROCTER & GAMBLE | 2014-02-05 | — | — | CN | disclosed |
| US-8389466-B2 | Use of carboxylic acid esters as a fragrance substance | SYMRISE AG (DE) | 2013-03-05 | — | — | US | disclosed |
| EP-2274409-B1 | USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE | SYMRISE AG (DE) | 2011-10-12 | — | — | EP | disclosed |
| US-20110104092-A1 | USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE | SYMRISE AG (DE) | 2011-05-05 | — | — | US | disclosed |
| EP-2274409-A1 | USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE | Symrise AG (DE) | 2011-01-19 | — | — | EP | disclosed |
| EP-1555261-B1 | VALEROLACTONE COMPOUNDS AND PERFUME COMPOSITION | KAO CORP (JP) | 2010-09-01 | — | — | EP | disclosed |
| CN-101617036-A | Benefit agent delivery compositions | PROCTER & GAMBLE | 2009-12-30 | — | — | CN | disclosed |
| CN-101611129-A | Benefit agent delivery compositions | PROCTER & GAMBLE (US) | 2009-12-23 | — | — | CN | disclosed |
| WO-2009124888-A1 | USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2009-10-15 | — | — | WO | disclosed |
| US-7491833-B2 | Valerolactone compounds and perfume composition | KAO CORPORATION (JP) | 2009-02-17 | — | — | US | disclosed |
| CN-100384727-C | Carrier based on granules produced from pyrogenically prepared silicon dioxides | DEGUSSA (DE) | 2008-04-30 | — | — | CN | disclosed |
| CN-100374432-C | Acetonide fragrance compound | INT FLAVORS & FRAGRANCES INC (US) | 2008-03-12 | — | — | CN | disclosed |
| US-20060258559-A1 | Valerolactone compounds and perfume composition | KAO CORPORATION (JP) | 2006-11-16 | — | — | US | disclosed |
| CN-1835890-A | Carrier based on granules produced from pyrogenically prepared silicon dioxides | DEGUSSA (DE) | 2006-09-20 | — | — | CN | disclosed |
| EP-1555261-A1 | VALEROLACTONE COMPOUNDS AND PERFUME COMPOSITION | Kao Corporation (JP) | 2005-07-20 | — | — | EP | disclosed |
| CN-1576360-A | Acetonide fragrance compound | INT FLAVORS & FRAGRANCES INC (US) | 2005-02-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104092-A1 | USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE | FASN, ELOVL5, ALDH16A1 | KMT2A 1635/4885KCNN4 3991/4885KIF11 3691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.